INS and early-onset autosomal dominant Alzheimer disease: SCFAs are known to reduce intestinal inflammatory activity [21], and MCFAs contribute to energy supply in insulin-resistant tissues, potentially enhancing brain metabolism and playing a role in Alzheimer’s disease prevention [22].